Paul-andre De Lame
Chief Medical Officer
Pharmaceutical sciences
Aridis Pharmaceuticals
United States of America
Biography
Dr. de Lame is an intensive care medical expert with strong experience in cardiovascular medicine and infectious diseases. He was a former executive at Merck and Warner Lambert (Pfizer) where he focused on clinical development at Merck and Warner-Lambert (Pfizer). He was also the co-founder and Chief Medical Officer of Cardiokine Inc. and the Chief Executive Officer of Anabase International Corp., which provides regulatory and clinical research services. Dr. de Lame was a key contributor to many product development teams involving several vaccines and antibiotics. He was also principally involved with the clinical development of Lipitor® (atorvastatin) and the life cycle management of imipenem/cilastatin (Tienam®, Primaxin®), gemfibrozil, quinapril (Accupril®), norfloxacin and several medical devices. Dr. de Lame received his M.D. from the Universite Catholique de Louvain, with a specialization in anesthesiology and intensive care.
Research Interest
cardiovascular medicine and infectious diseases
